Thanendrarajan, S., Tian, E., Qu, P., Mathur, P., Schinke, C., van Rhee, F., Zangari, M., Rasche, L., Weinhold, N., Alapat, D., Bellamy, W., Ashby, C., Mattox, S., Epstein, J., Yaccoby, S., Barlogie, B., Hoering, A., Bauer, M., Walker, B. A., Davies, F. E. and Morgan, G. J. (2017) “The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma”, Haematologica. Pavia, Italy, 102(9), pp. e364-e367. doi: 10.3324/haematol.2017.168872.